

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | urate metabolic process (GO:0046415) | 7.50177905 |
| 2 | drug transmembrane transport (GO:0006855) | 6.68900644 |
| 3 | folic acid metabolic process (GO:0046655) | 6.50991220 |
| 4 | drug transport (GO:0015893) | 6.45230672 |
| 5 | modified amino acid transport (GO:0072337) | 6.11711887 |
| 6 | folic acid transport (GO:0015884) | 5.91140400 |
| 7 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.85812706 |
| 8 | detection of molecule of bacterial origin (GO:0032490) | 5.79108266 |
| 9 | phosphate ion transport (GO:0006817) | 5.59482260 |
| 10 | leukotriene biosynthetic process (GO:0019370) | 5.39402310 |
| 11 | fructose metabolic process (GO:0006000) | 5.31058022 |
| 12 | lysine catabolic process (GO:0006554) | 5.20764989 |
| 13 | lysine metabolic process (GO:0006553) | 5.20764989 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 5.19048408 |
| 15 | modulation by symbiont of host defense response (GO:0052031) | 5.19048408 |
| 16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.19048408 |
| 17 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.19048408 |
| 18 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.19048408 |
| 19 | modulation by symbiont of host immune response (GO:0052553) | 5.19048408 |
| 20 | interferon-gamma secretion (GO:0072643) | 5.15768320 |
| 21 | organic cation transport (GO:0015695) | 5.08358279 |
| 22 | phosphate ion transmembrane transport (GO:0035435) | 5.03079887 |
| 23 | cellular extravasation (GO:0045123) | 4.89357516 |
| 24 | negative regulation of cAMP-mediated signaling (GO:0043951) | 4.79478726 |
| 25 | neutrophil activation involved in immune response (GO:0002283) | 4.76712353 |
| 26 | cysteine metabolic process (GO:0006534) | 4.75780009 |
| 27 | leukotriene metabolic process (GO:0006691) | 4.74864827 |
| 28 | vitamin D metabolic process (GO:0042359) | 4.69173891 |
| 29 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.67690922 |
| 30 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.67017984 |
| 31 | drug catabolic process (GO:0042737) | 4.58282594 |
| 32 | NADH metabolic process (GO:0006734) | 4.53858738 |
| 33 | quaternary ammonium group transport (GO:0015697) | 4.53715551 |
| 34 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.52317787 |
| 35 | negative regulation of cell killing (GO:0031342) | 4.39323148 |
| 36 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.39323148 |
| 37 | excretion (GO:0007588) | 4.38267222 |
| 38 | vitamin transport (GO:0051180) | 4.33939284 |
| 39 | serine family amino acid metabolic process (GO:0009069) | 4.33855610 |
| 40 | macrophage activation involved in immune response (GO:0002281) | 4.29791494 |
| 41 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 4.29273012 |
| 42 | serine family amino acid catabolic process (GO:0009071) | 4.27666807 |
| 43 | microglial cell activation (GO:0001774) | 4.23068531 |
| 44 | glyoxylate metabolic process (GO:0046487) | 4.16803321 |
| 45 | neutrophil activation (GO:0042119) | 4.13506085 |
| 46 | purine nucleobase biosynthetic process (GO:0009113) | 4.12594977 |
| 47 | serine family amino acid biosynthetic process (GO:0009070) | 4.12073048 |
| 48 | tricarboxylic acid metabolic process (GO:0072350) | 4.11652556 |
| 49 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.08240901 |
| 50 | detection of external biotic stimulus (GO:0098581) | 4.03116799 |
| 51 | oligosaccharide catabolic process (GO:0009313) | 3.98109776 |
| 52 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.96853504 |
| 53 | toxin transport (GO:1901998) | 3.94621838 |
| 54 | exogenous drug catabolic process (GO:0042738) | 3.94615222 |
| 55 | renal absorption (GO:0070293) | 3.94447877 |
| 56 | pantothenate metabolic process (GO:0015939) | 3.88703717 |
| 57 | homocysteine metabolic process (GO:0050667) | 3.87077542 |
| 58 | response to peptidoglycan (GO:0032494) | 3.85626134 |
| 59 | neutrophil mediated immunity (GO:0002446) | 3.85354683 |
| 60 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.81608348 |
| 61 | myeloid leukocyte mediated immunity (GO:0002444) | 3.76531600 |
| 62 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.76342792 |
| 63 | response to mercury ion (GO:0046689) | 3.75499868 |
| 64 | cell wall macromolecule catabolic process (GO:0016998) | 3.74532779 |
| 65 | proteasome assembly (GO:0043248) | 3.74442229 |
| 66 | glutathione biosynthetic process (GO:0006750) | 3.72120841 |
| 67 | amino sugar catabolic process (GO:0046348) | 3.71530369 |
| 68 | granulocyte activation (GO:0036230) | 3.71112707 |
| 69 | positive regulation of mast cell activation (GO:0033005) | 3.66754865 |
| 70 | branched-chain amino acid metabolic process (GO:0009081) | 3.64914655 |
| 71 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.63773408 |
| 72 | carnitine transport (GO:0015879) | 3.62669292 |
| 73 | amino-acid betaine transport (GO:0015838) | 3.62669292 |
| 74 | cell wall macromolecule metabolic process (GO:0044036) | 3.61940552 |
| 75 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.61464130 |
| 76 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.61464130 |
| 77 | alditol metabolic process (GO:0019400) | 3.60972166 |
| 78 | ribosome assembly (GO:0042255) | 3.59128788 |
| 79 | amino-acid betaine metabolic process (GO:0006577) | 3.58049326 |
| 80 | nucleobase biosynthetic process (GO:0046112) | 3.56746464 |
| 81 | aspartate family amino acid catabolic process (GO:0009068) | 3.52505117 |
| 82 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.52342174 |
| 83 | response to host immune response (GO:0052572) | 3.52342174 |
| 84 | macrophage activation (GO:0042116) | 3.50723336 |
| 85 | heme transport (GO:0015886) | 3.49843730 |
| 86 | locomotory exploration behavior (GO:0035641) | 3.49817324 |
| 87 | negative regulation of interleukin-12 production (GO:0032695) | 3.49401031 |
| 88 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.49046553 |
| 89 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.48343352 |
| 90 | glycine metabolic process (GO:0006544) | 3.47515664 |
| 91 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.46860591 |
| 92 | positive regulation of mast cell degranulation (GO:0043306) | 3.46860591 |
| 93 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.44291904 |
| 94 | folic acid-containing compound metabolic process (GO:0006760) | 3.42003761 |
| 95 | phosphate ion homeostasis (GO:0055062) | 3.41731365 |
| 96 | trivalent inorganic anion homeostasis (GO:0072506) | 3.41731365 |
| 97 | detection of biotic stimulus (GO:0009595) | 3.41597251 |
| 98 | regulation of mast cell activation (GO:0033003) | 3.41169237 |
| 99 | vitamin transmembrane transport (GO:0035461) | 3.40952804 |
| 100 | myeloid cell activation involved in immune response (GO:0002275) | 3.39018996 |
| 101 | regulation of mast cell degranulation (GO:0043304) | 3.36099147 |
| 102 | biotin metabolic process (GO:0006768) | 3.35408994 |
| 103 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.34449870 |
| 104 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.34190329 |
| 105 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.30133396 |
| 106 | sulfur compound transport (GO:0072348) | 3.28961933 |
| 107 | branched-chain amino acid catabolic process (GO:0009083) | 3.28859108 |
| 108 | proline metabolic process (GO:0006560) | 3.28787597 |
| 109 | detection of other organism (GO:0098543) | 3.28729612 |
| 110 | regulation of beta-amyloid formation (GO:1902003) | 3.27743614 |
| 111 | metanephric nephron tubule development (GO:0072234) | 3.26471580 |
| 112 | metanephric tubule development (GO:0072170) | 3.26471580 |
| 113 | tricarboxylic acid cycle (GO:0006099) | 3.26465180 |
| 114 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.26128223 |
| 115 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.25789999 |
| 116 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.25422279 |
| 117 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.25366275 |
| 118 | oxygen transport (GO:0015671) | 3.24540293 |
| 119 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.22926788 |
| 120 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.20675603 |
| 121 | intestinal epithelial cell development (GO:0060576) | 3.20653087 |
| 122 | regulation of neuron projection regeneration (GO:0070570) | 3.20431396 |
| 123 | regulation of axon regeneration (GO:0048679) | 3.20431396 |
| 124 | positive regulation of granulocyte differentiation (GO:0030854) | 3.19670333 |
| 125 | lung-associated mesenchyme development (GO:0060484) | 3.18541525 |
| 126 | response to interleukin-15 (GO:0070672) | 3.18403287 |
| 127 | sulfur amino acid biosynthetic process (GO:0000097) | 3.17695365 |
| 128 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.15956176 |
| 129 | sulfur amino acid metabolic process (GO:0000096) | 3.14743616 |
| 130 | cofactor transport (GO:0051181) | 3.13502827 |
| 131 | negative regulation of B cell mediated immunity (GO:0002713) | 3.12713787 |
| 132 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.12713787 |
| 133 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.11488852 |
| 134 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.10392047 |
| 135 | regulation of mitochondrial translation (GO:0070129) | 3.10277851 |
| 136 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.10259660 |
| 137 | regulation of gamma-delta T cell activation (GO:0046643) | 3.10222744 |
| 138 | labyrinthine layer development (GO:0060711) | 3.09915656 |
| 139 | germinal center formation (GO:0002467) | 3.09518972 |
| 140 | glycoside metabolic process (GO:0016137) | 3.08463316 |
| 141 | formation of translation preinitiation complex (GO:0001731) | 3.07487202 |
| 142 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.06901376 |
| 143 | positive regulation of vasculogenesis (GO:2001214) | 3.06794436 |
| 144 | valine metabolic process (GO:0006573) | 3.06393325 |
| 145 | iron ion import (GO:0097286) | 3.05008346 |
| 146 | 2-oxoglutarate metabolic process (GO:0006103) | 3.04187472 |
| 147 | negative regulation of type 2 immune response (GO:0002829) | 3.03760753 |
| 148 | ADP metabolic process (GO:0046031) | 3.02866926 |
| 149 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 3.01641664 |
| 150 | cellular response to interleukin-15 (GO:0071350) | 3.01541864 |
| 151 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.99236099 |
| 152 | response to host (GO:0075136) | 2.98906785 |
| 153 | response to host defenses (GO:0052200) | 2.98906785 |
| 154 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.98906785 |
| 155 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.98229941 |
| 156 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.97675026 |
| 157 | short-chain fatty acid metabolic process (GO:0046459) | 2.97519400 |
| 158 | metanephric nephron epithelium development (GO:0072243) | 2.96990826 |
| 159 | establishment of protein localization to Golgi (GO:0072600) | 2.96799803 |
| 160 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.95515829 |
| 161 | leukocyte degranulation (GO:0043299) | 2.91699655 |
| 162 | protein targeting to Golgi (GO:0000042) | 2.91660946 |
| 163 | natural killer cell differentiation (GO:0001779) | 2.89514318 |
| 164 | carnitine metabolic process (GO:0009437) | 2.87599769 |
| 165 | gas transport (GO:0015669) | 2.87286810 |
| 166 | negative regulation of ligase activity (GO:0051352) | 2.87017460 |
| 167 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.87017460 |
| 168 | leukocyte aggregation (GO:0070486) | 2.86547419 |
| 169 | peptide biosynthetic process (GO:0043043) | 2.85249623 |
| 170 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.84800972 |
| 171 | glutathione derivative biosynthetic process (GO:1901687) | 2.84485036 |
| 172 | glutathione derivative metabolic process (GO:1901685) | 2.84485036 |
| 173 | erythrocyte development (GO:0048821) | 2.83187773 |
| 174 | respiratory burst (GO:0045730) | 2.83135683 |
| 175 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.83019531 |
| 176 | regulation of histone H3-K27 methylation (GO:0061085) | 2.82518641 |
| 177 | water-soluble vitamin metabolic process (GO:0006767) | 2.80265572 |
| 178 | aspartate family amino acid metabolic process (GO:0009066) | 2.78868689 |
| 179 | positive regulation of ligase activity (GO:0051351) | 2.77708192 |
| 180 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.77555168 |
| 181 | pteridine-containing compound metabolic process (GO:0042558) | 2.77135010 |
| 182 | B cell receptor signaling pathway (GO:0050853) | 2.76562316 |
| 183 | icosanoid biosynthetic process (GO:0046456) | 2.75746104 |
| 184 | fatty acid derivative biosynthetic process (GO:1901570) | 2.75746104 |
| 185 | positive regulation of macrophage cytokine production (GO:0060907) | 2.75459400 |
| 186 | AMP metabolic process (GO:0046033) | 2.75112189 |
| 187 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.74685766 |
| 188 | dicarboxylic acid metabolic process (GO:0043648) | 2.74414997 |
| 189 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.74221579 |
| 190 | L-phenylalanine metabolic process (GO:0006558) | 2.74221579 |
| 191 | blastocyst development (GO:0001824) | 2.74111448 |
| 192 | regulation of macrophage cytokine production (GO:0010935) | 2.73475606 |
| 193 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.73359482 |
| 194 | signal peptide processing (GO:0006465) | 2.73019034 |
| 195 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.72804463 |
| 196 | serotonin metabolic process (GO:0042428) | 2.71770436 |
| 197 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.71418328 |
| 198 | peptide catabolic process (GO:0043171) | 2.71064144 |
| 199 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.68567853 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.07711007 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.86566477 |
| 3 | AR_21909140_ChIP-Seq_LNCAP_Human | 3.45207797 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.33488102 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.28078999 |
| 6 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.23301853 |
| 7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.23075762 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.22514400 |
| 9 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.16095820 |
| 10 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.04906009 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.02832893 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 3.01255358 |
| 13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.01059574 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.95472516 |
| 15 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.95315234 |
| 16 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.92930329 |
| 17 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.83242586 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.67655740 |
| 19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.61127176 |
| 20 | VDR_22108803_ChIP-Seq_LS180_Human | 2.59605727 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.58455059 |
| 22 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.52517905 |
| 23 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.47493777 |
| 24 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.41907260 |
| 25 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.41316970 |
| 26 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.40730746 |
| 27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.38065355 |
| 28 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.37467871 |
| 29 | SPI1_23127762_ChIP-Seq_K562_Human | 2.36635049 |
| 30 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.28986123 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.28339850 |
| 32 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.24064815 |
| 33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.23985263 |
| 34 | GATA1_19941826_ChIP-Seq_K562_Human | 2.22945104 |
| 35 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.22051611 |
| 36 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 2.20063491 |
| 37 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.19191353 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.18447231 |
| 39 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.17375782 |
| 40 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.14750725 |
| 41 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.07265546 |
| 42 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.02574641 |
| 43 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.00461875 |
| 44 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.99920473 |
| 45 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.99308282 |
| 46 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.94707844 |
| 47 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.94196217 |
| 48 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.93805125 |
| 49 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.92161904 |
| 50 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.91651440 |
| 51 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.88282514 |
| 52 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.86311375 |
| 53 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.86072242 |
| 54 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.85206502 |
| 55 | MYB_26560356_Chip-Seq_TH2_Human | 1.84701780 |
| 56 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.84161875 |
| 57 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.82790953 |
| 58 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.82480328 |
| 59 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.80398028 |
| 60 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.77800428 |
| 61 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.75603945 |
| 62 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.73940774 |
| 63 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.71909635 |
| 64 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.71151636 |
| 65 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.68686879 |
| 66 | GATA2_19941826_ChIP-Seq_K562_Human | 1.67292196 |
| 67 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.66726448 |
| 68 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.66316442 |
| 69 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.65907375 |
| 70 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.63619517 |
| 71 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.63468199 |
| 72 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.62855767 |
| 73 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.61749171 |
| 74 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.60064350 |
| 75 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.59827144 |
| 76 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.58406018 |
| 77 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57819553 |
| 78 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.56184574 |
| 79 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.55271753 |
| 80 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.55250014 |
| 81 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.54749738 |
| 82 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.53924669 |
| 83 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53468003 |
| 84 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.52270354 |
| 85 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.51321073 |
| 86 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.51318258 |
| 87 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.48941584 |
| 88 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.47975554 |
| 89 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.47822439 |
| 90 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.47614675 |
| 91 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.47164739 |
| 92 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.46298544 |
| 93 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.45475908 |
| 94 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.43003177 |
| 95 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42201331 |
| 96 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.42005647 |
| 97 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.41304837 |
| 98 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.39871336 |
| 99 | GATA3_26560356_Chip-Seq_TH2_Human | 1.39670193 |
| 100 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.39420653 |
| 101 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38582451 |
| 102 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.37480067 |
| 103 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.36216792 |
| 104 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.36206486 |
| 105 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.35995301 |
| 106 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.35134284 |
| 107 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34410063 |
| 108 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.34328385 |
| 109 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.32608279 |
| 110 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.31926209 |
| 111 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.31679005 |
| 112 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.31096535 |
| 113 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30561290 |
| 114 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.30291525 |
| 115 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.29688038 |
| 116 | GATA3_26560356_Chip-Seq_TH1_Human | 1.28824066 |
| 117 | MYB_26560356_Chip-Seq_TH1_Human | 1.26447300 |
| 118 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.25193921 |
| 119 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24980994 |
| 120 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.24860287 |
| 121 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.24825088 |
| 122 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.24363638 |
| 123 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.24325128 |
| 124 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.23083707 |
| 125 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.21875957 |
| 126 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.19516881 |
| 127 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.18347495 |
| 128 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.17860285 |
| 129 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16213610 |
| 130 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.16061812 |
| 131 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.14800591 |
| 132 | MAF_26560356_Chip-Seq_TH1_Human | 1.14201961 |
| 133 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.13702966 |
| 134 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.12426131 |
| 135 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.12313119 |
| 136 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.11332364 |
| 137 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.10957468 |
| 138 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.10833603 |
| 139 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10389793 |
| 140 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.10053561 |
| 141 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.07728757 |
| 142 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.07547143 |
| 143 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.07286439 |
| 144 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.06955412 |
| 145 | ATF3_27146783_Chip-Seq_COLON_Human | 1.06735272 |
| 146 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.05794680 |
| 147 | RXR_22108803_ChIP-Seq_LS180_Human | 1.05673672 |
| 148 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.05582673 |
| 149 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.05082822 |
| 150 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.04535122 |
| 151 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03426821 |
| 152 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.03421001 |
| 153 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.03102841 |
| 154 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.02961180 |
| 155 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.02115231 |
| 156 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.01649114 |
| 157 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01404700 |
| 158 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.01053155 |
| 159 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99770739 |
| 160 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.99316389 |
| 161 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.98325023 |
| 162 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.98155217 |
| 163 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.97249807 |
| 164 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.96769607 |
| 165 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.95910980 |
| 166 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.95286562 |
| 167 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.94852371 |
| 168 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.94843795 |
| 169 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94029228 |
| 170 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.93544211 |
| 171 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.93318558 |
| 172 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.92865532 |
| 173 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.92574328 |
| 174 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.92434092 |
| 175 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.92136234 |
| 176 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91952918 |
| 177 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91157109 |
| 178 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.89983863 |
| 179 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.89916168 |
| 180 | UTX_26944678_Chip-Seq_JUKART_Human | 0.89611336 |
| 181 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.88794336 |
| 182 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.88660242 |
| 183 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.87881032 |
| 184 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.87795977 |
| 185 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.87194412 |
| 186 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.86314510 |
| 187 | STAT3_23295773_ChIP-Seq_U87_Human | 0.86119671 |
| 188 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.85615565 |
| 189 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.85376636 |
| 190 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.84783615 |
| 191 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.84368673 |
| 192 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.82906732 |
| 193 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.82228523 |
| 194 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.82228523 |
| 195 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.81630730 |
| 196 | BCL6_25482012_ChIP-Seq_CML-JURL-MK1_Human | 0.80915617 |
| 197 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.80680949 |
| 198 | TP53_16413492_ChIP-PET_HCT116_Human | 0.79263900 |
| 199 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79081946 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003183_abnormal_peptide_metabolism | 5.21213100 |
| 2 | MP0003724_increased_susceptibility_to | 5.07933944 |
| 3 | MP0005360_urolithiasis | 4.68966564 |
| 4 | MP0003195_calcinosis | 4.45164068 |
| 5 | MP0004043_abnormal_pH_regulation | 4.44792944 |
| 6 | MP0005332_abnormal_amino_acid | 4.29826009 |
| 7 | * MP0004019_abnormal_vitamin_homeostasis | 4.28034662 |
| 8 | MP0003693_abnormal_embryo_hatching | 3.80651924 |
| 9 | MP0005377_hearing/vestibular/ear_phenot | 3.79784194 |
| 10 | MP0003878_abnormal_ear_physiology | 3.79784194 |
| 11 | MP0009840_abnormal_foam_cell | 3.42976396 |
| 12 | * MP0009643_abnormal_urine_homeostasis | 3.42194892 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 3.37059750 |
| 14 | MP0003303_peritoneal_inflammation | 3.21979401 |
| 15 | * MP0001756_abnormal_urination | 3.11768576 |
| 16 | MP0002139_abnormal_hepatobiliary_system | 3.09425937 |
| 17 | MP0001986_abnormal_taste_sensitivity | 2.70812095 |
| 18 | MP0005636_abnormal_mineral_homeostasis | 2.70613815 |
| 19 | MP0004381_abnormal_hair_follicle | 2.66856652 |
| 20 | * MP0001765_abnormal_ion_homeostasis | 2.65489806 |
| 21 | * MP0002136_abnormal_kidney_physiology | 2.60153187 |
| 22 | MP0004957_abnormal_blastocyst_morpholog | 2.56131939 |
| 23 | MP0003111_abnormal_nucleus_morphology | 2.55416374 |
| 24 | MP0003656_abnormal_erythrocyte_physiolo | 2.47528147 |
| 25 | MP0003806_abnormal_nucleotide_metabolis | 2.39576552 |
| 26 | MP0003436_decreased_susceptibility_to | 2.38268688 |
| 27 | MP0002419_abnormal_innate_immunity | 2.25165340 |
| 28 | MP0005671_abnormal_response_to | 2.19049767 |
| 29 | MP0003186_abnormal_redox_activity | 2.15146905 |
| 30 | MP0005365_abnormal_bile_salt | 2.13154142 |
| 31 | MP0000685_abnormal_immune_system | 2.09108078 |
| 32 | MP0003718_maternal_effect | 2.06883593 |
| 33 | MP0001835_abnormal_antigen_presentation | 2.06712890 |
| 34 | MP0005058_abnormal_lysosome_morphology | 2.01375055 |
| 35 | MP0001800_abnormal_humoral_immune | 1.95681593 |
| 36 | MP0001958_emphysema | 1.83069169 |
| 37 | MP0008877_abnormal_DNA_methylation | 1.77915267 |
| 38 | MP0005025_abnormal_response_to | 1.77643474 |
| 39 | MP0004130_abnormal_muscle_cell | 1.77507459 |
| 40 | MP0002420_abnormal_adaptive_immunity | 1.76013620 |
| 41 | MP0008875_abnormal_xenobiotic_pharmacok | 1.75373712 |
| 42 | MP0001819_abnormal_immune_cell | 1.74930482 |
| 43 | MP0008260_abnormal_autophagy | 1.73563538 |
| 44 | MP0002723_abnormal_immune_serum | 1.73471731 |
| 45 | MP0002452_abnormal_antigen_presenting | 1.71987924 |
| 46 | MP0005000_abnormal_immune_tolerance | 1.70631120 |
| 47 | MP0005451_abnormal_body_composition | 1.66234543 |
| 48 | MP0003690_abnormal_glial_cell | 1.62673607 |
| 49 | MP0002132_abnormal_respiratory_system | 1.61822459 |
| 50 | MP0008057_abnormal_DNA_replication | 1.60817144 |
| 51 | MP0005395_other_phenotype | 1.60261125 |
| 52 | MP0003315_abnormal_perineum_morphology | 1.59393532 |
| 53 | MP0005085_abnormal_gallbladder_physiolo | 1.59237824 |
| 54 | MP0001790_abnormal_immune_system | 1.56312302 |
| 55 | MP0005387_immune_system_phenotype | 1.56312302 |
| 56 | MP0002009_preneoplasia | 1.55508768 |
| 57 | MP0002653_abnormal_ependyma_morphology | 1.54803804 |
| 58 | MP0005084_abnormal_gallbladder_morpholo | 1.54398659 |
| 59 | MP0000569_abnormal_digit_pigmentation | 1.51597540 |
| 60 | MP0009785_altered_susceptibility_to | 1.50574993 |
| 61 | MP0003172_abnormal_lysosome_physiology | 1.49017751 |
| 62 | MP0006036_abnormal_mitochondrial_physio | 1.48328135 |
| 63 | MP0005310_abnormal_salivary_gland | 1.45332966 |
| 64 | MP0009278_abnormal_bone_marrow | 1.44751294 |
| 65 | MP0006082_CNS_inflammation | 1.44214224 |
| 66 | MP0004742_abnormal_vestibular_system | 1.43764061 |
| 67 | MP0004885_abnormal_endolymph | 1.42476242 |
| 68 | MP0005167_abnormal_blood-brain_barrier | 1.42194042 |
| 69 | MP0001545_abnormal_hematopoietic_system | 1.41194724 |
| 70 | MP0005397_hematopoietic_system_phenotyp | 1.41194724 |
| 71 | MP0002722_abnormal_immune_system | 1.40554588 |
| 72 | MP0003646_muscle_fatigue | 1.38474920 |
| 73 | MP0002398_abnormal_bone_marrow | 1.38286180 |
| 74 | MP0002405_respiratory_system_inflammati | 1.37175892 |
| 75 | MP0000689_abnormal_spleen_morphology | 1.36298071 |
| 76 | MP0001501_abnormal_sleep_pattern | 1.36261353 |
| 77 | MP0003077_abnormal_cell_cycle | 1.35596065 |
| 78 | MP0002148_abnormal_hypersensitivity_rea | 1.34131556 |
| 79 | MP0009764_decreased_sensitivity_to | 1.33441266 |
| 80 | MP0001730_embryonic_growth_arrest | 1.32103529 |
| 81 | MP0002735_abnormal_chemical_nociception | 1.31487787 |
| 82 | MP0008932_abnormal_embryonic_tissue | 1.31482044 |
| 83 | MP0001661_extended_life_span | 1.30871990 |
| 84 | MP0002168_other_aberrant_phenotype | 1.28752477 |
| 85 | MP0004264_abnormal_extraembryonic_tissu | 1.28623099 |
| 86 | MP0003252_abnormal_bile_duct | 1.27811210 |
| 87 | * MP0000716_abnormal_immune_system | 1.27370590 |
| 88 | MP0003763_abnormal_thymus_physiology | 1.27019942 |
| 89 | MP0001727_abnormal_embryo_implantation | 1.26688257 |
| 90 | MP0005379_endocrine/exocrine_gland_phen | 1.26218673 |
| 91 | MP0002277_abnormal_respiratory_mucosa | 1.23021319 |
| 92 | MP0006035_abnormal_mitochondrial_morpho | 1.22248288 |
| 93 | MP0000703_abnormal_thymus_morphology | 1.19041983 |
| 94 | MP0005464_abnormal_platelet_physiology | 1.18926870 |
| 95 | MP0001764_abnormal_homeostasis | 1.18133720 |
| 96 | MP0001533_abnormal_skeleton_physiology | 1.18108325 |
| 97 | MP0005319_abnormal_enzyme/_coenzyme | 1.16426433 |
| 98 | MP0002796_impaired_skin_barrier | 1.15642808 |
| 99 | MP0005423_abnormal_somatic_nervous | 1.14249619 |
| 100 | MP0010234_abnormal_vibrissa_follicle | 1.14146288 |
| 101 | MP0000465_gastrointestinal_hemorrhage | 1.11110806 |
| 102 | MP0001845_abnormal_inflammatory_respons | 1.11093998 |
| 103 | MP0002163_abnormal_gland_morphology | 1.10440190 |
| 104 | MP0001440_abnormal_grooming_behavior | 1.10146377 |
| 105 | MP0009765_abnormal_xenobiotic_induced | 1.09422174 |
| 106 | MP0010352_gastrointestinal_tract_polyps | 1.09044669 |
| 107 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.03023760 |
| 108 | MP0002064_seizures | 1.01133944 |
| 109 | MP0005083_abnormal_biliary_tract | 1.00959000 |
| 110 | MP0010094_abnormal_chromosome_stability | 1.00692024 |
| 111 | MP0002135_abnormal_kidney_morphology | 0.98407482 |
| 112 | MP0003221_abnormal_cardiomyocyte_apopto | 0.98231079 |
| 113 | MP0003567_abnormal_fetal_cardiomyocyte | 0.97163567 |
| 114 | * MP0002429_abnormal_blood_cell | 0.97136943 |
| 115 | MP0002166_altered_tumor_susceptibility | 0.93807766 |
| 116 | MP0002876_abnormal_thyroid_physiology | 0.93429311 |
| 117 | MP0002272_abnormal_nervous_system | 0.93303230 |
| 118 | MP0000920_abnormal_myelination | 0.93006317 |
| 119 | MP0001485_abnormal_pinna_reflex | 0.92912023 |
| 120 | MP0009046_muscle_twitch | 0.92827264 |
| 121 | MP0000358_abnormal_cell_content/ | 0.92270852 |
| 122 | MP0002971_abnormal_brown_adipose | 0.91352397 |
| 123 | MP0003786_premature_aging | 0.89980271 |
| 124 | MP0001697_abnormal_embryo_size | 0.87471274 |
| 125 | MP0001672_abnormal_embryogenesis/_devel | 0.87103499 |
| 126 | MP0005380_embryogenesis_phenotype | 0.87103499 |
| 127 | MP0002909_abnormal_adrenal_gland | 0.86962784 |
| 128 | MP0003828_pulmonary_edema | 0.85600355 |
| 129 | MP0009745_abnormal_behavioral_response | 0.83491809 |
| 130 | MP0003075_altered_response_to | 0.83388010 |
| 131 | MP0003191_abnormal_cellular_cholesterol | 0.82460762 |
| 132 | MP0004510_myositis | 0.81636676 |
| 133 | MP0004883_abnormal_blood_vessel | 0.81121266 |
| 134 | MP0005501_abnormal_skin_physiology | 0.80154432 |
| 135 | MP0000747_muscle_weakness | 0.79929071 |
| 136 | MP0003984_embryonic_growth_retardation | 0.79898582 |
| 137 | MP0002088_abnormal_embryonic_growth/wei | 0.79744267 |
| 138 | MP0000371_diluted_coat_color | 0.79220845 |
| 139 | MP0008469_abnormal_protein_level | 0.78783828 |
| 140 | MP0003329_amyloid_beta_deposits | 0.77092908 |
| 141 | MP0003631_nervous_system_phenotype | 0.76673826 |
| 142 | MP0002080_prenatal_lethality | 0.76257341 |
| 143 | MP0004142_abnormal_muscle_tone | 0.75727854 |
| 144 | MP0004947_skin_inflammation | 0.75520485 |
| 145 | MP0000427_abnormal_hair_cycle | 0.74926346 |
| 146 | MP0002098_abnormal_vibrissa_morphology | 0.74353593 |
| 147 | MP0004147_increased_porphyrin_level | 0.74227187 |
| 148 | MP0005164_abnormal_response_to | 0.74195859 |
| 149 | MP0003959_abnormal_lean_body | 0.74027433 |
| 150 | MP0000609_abnormal_liver_physiology | 0.73827343 |
| 151 | MP0003045_fibrosis | 0.73693854 |
| 152 | MP0002229_neurodegeneration | 0.73600690 |
| 153 | MP0003632_abnormal_nervous_system | 0.73510763 |
| 154 | MP0001486_abnormal_startle_reflex | 0.73491501 |
| 155 | MP0003633_abnormal_nervous_system | 0.73449895 |
| 156 | MP0002118_abnormal_lipid_homeostasis | 0.73236574 |
| 157 | MP0001666_abnormal_nutrient_absorption | 0.73215974 |
| 158 | MP0005670_abnormal_white_adipose | 0.72954226 |
| 159 | MP0001542_abnormal_bone_strength | 0.71655354 |
| 160 | MP0005666_abnormal_adipose_tissue | 0.71192425 |
| 161 | MP0005075_abnormal_melanosome_morpholog | 0.71022434 |
| 162 | MP0002086_abnormal_extraembryonic_tissu | 0.69250048 |
| 163 | MP0000598_abnormal_liver_morphology | 0.68613787 |
| 164 | MP0005408_hypopigmentation | 0.68590798 |
| 165 | MP0009672_abnormal_birth_weight | 0.67197783 |
| 166 | MP0000377_abnormal_hair_follicle | 0.66869459 |
| 167 | MP0008058_abnormal_DNA_repair | 0.64663160 |
| 168 | MP0000537_abnormal_urethra_morphology | 0.60715420 |
| 169 | MP0010329_abnormal_lipoprotein_level | 0.58199391 |
| 170 | MP0009642_abnormal_blood_homeostasis | 0.57534970 |
| 171 | MP0003300_gastrointestinal_ulcer | 0.57007383 |
| 172 | MP0000230_abnormal_systemic_arterial | 0.56347047 |
| 173 | MP0003866_abnormal_defecation | 0.54266123 |
| 174 | MP0000538_abnormal_urinary_bladder | 0.52032403 |
| 175 | MP0005330_cardiomyopathy | 0.51815077 |
| 176 | MP0002085_abnormal_embryonic_tissue | 0.51229918 |
| 177 | MP0003938_abnormal_ear_development | 0.51102697 |
| 178 | MP0001216_abnormal_epidermal_layer | 0.50103689 |
| 179 | MP0000490_abnormal_crypts_of | 0.48848185 |
| 180 | MP0000477_abnormal_intestine_morphology | 0.48067700 |
| 181 | MP0003638_abnormal_response/metabolism_ | 0.47790167 |
| 182 | MP0004484_altered_response_of | 0.47694984 |
| 183 | MP0003879_abnormal_hair_cell | 0.47655974 |
| 184 | MP0001145_abnormal_male_reproductive | 0.46547998 |
| 185 | MP0004084_abnormal_cardiac_muscle | 0.46507107 |
| 186 | MP0000350_abnormal_cell_proliferation | 0.46118133 |
| 187 | MP0002396_abnormal_hematopoietic_system | 0.45866040 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Gout (HP:0001997) | 6.86753833 |
| 2 | Increased circulating renin level (HP:0000848) | 6.55899897 |
| 3 | Hypokalemic alkalosis (HP:0001949) | 6.09948746 |
| 4 | Proximal tubulopathy (HP:0000114) | 5.76783495 |
| 5 | Hypomagnesemia (HP:0002917) | 5.67756009 |
| 6 | Metabolic alkalosis (HP:0200114) | 5.66127282 |
| 7 | Polyuria (HP:0000103) | 5.44586675 |
| 8 | Hyperactive renin-angiotensin system (HP:0000841) | 5.43841638 |
| 9 | Abnormal urine output (HP:0012590) | 5.01027970 |
| 10 | Abnormality of chloride homeostasis (HP:0011422) | 4.98800051 |
| 11 | Abnormality of magnesium homeostasis (HP:0004921) | 4.98282932 |
| 12 | Hyperglycinuria (HP:0003108) | 4.83568758 |
| 13 | Abnormality of renal excretion (HP:0011036) | 4.73943045 |
| 14 | Increased purine levels (HP:0004368) | 4.57828338 |
| 15 | Hyperuricemia (HP:0002149) | 4.57828338 |
| 16 | Abnormality of glycine metabolism (HP:0010895) | 4.13280314 |
| 17 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.13280314 |
| 18 | Tetany (HP:0001281) | 4.11585972 |
| 19 | Eczematoid dermatitis (HP:0000976) | 4.08198460 |
| 20 | Alkalosis (HP:0001948) | 4.07068292 |
| 21 | Recurrent bacterial skin infections (HP:0005406) | 4.03274002 |
| 22 | Renal salt wasting (HP:0000127) | 4.00834603 |
| 23 | Keratoconjunctivitis sicca (HP:0001097) | 3.95768591 |
| 24 | Recurrent abscess formation (HP:0002722) | 3.87603880 |
| 25 | Myositis (HP:0100614) | 3.82239116 |
| 26 | Glycosuria (HP:0003076) | 3.79764581 |
| 27 | Abnormality of urine glucose concentration (HP:0011016) | 3.79764581 |
| 28 | Generalized aminoaciduria (HP:0002909) | 3.79591595 |
| 29 | Abnormality of renin-angiotensin system (HP:0000847) | 3.79146949 |
| 30 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.75429549 |
| 31 | Optic neuritis (HP:0100653) | 3.75289149 |
| 32 | Retrobulbar optic neuritis (HP:0100654) | 3.75289149 |
| 33 | Abnormal drinking behavior (HP:0030082) | 3.71098257 |
| 34 | Polydipsia (HP:0001959) | 3.71098257 |
| 35 | Orchitis (HP:0100796) | 3.69901098 |
| 36 | Abnormality of purine metabolism (HP:0004352) | 3.62419712 |
| 37 | Hyperaldosteronism (HP:0000859) | 3.62067512 |
| 38 | Increased cerebral lipofuscin (HP:0011813) | 3.56837194 |
| 39 | Hyperglycinemia (HP:0002154) | 3.56794865 |
| 40 | Keratoconjunctivitis (HP:0001096) | 3.55850864 |
| 41 | Abnormality of macrophages (HP:0004311) | 3.49775961 |
| 42 | Hypochromic microcytic anemia (HP:0004840) | 3.40751827 |
| 43 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.39711784 |
| 44 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.39507881 |
| 45 | Spontaneous hematomas (HP:0007420) | 3.38105983 |
| 46 | Microcytic anemia (HP:0001935) | 3.27627366 |
| 47 | Encephalitis (HP:0002383) | 3.26675692 |
| 48 | Hypercalciuria (HP:0002150) | 3.17021202 |
| 49 | Recurrent fungal infections (HP:0002841) | 3.02430347 |
| 50 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.99908912 |
| 51 | Dicarboxylic aciduria (HP:0003215) | 2.99908912 |
| 52 | Toxemia of pregnancy (HP:0100603) | 2.94246020 |
| 53 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.92752708 |
| 54 | Hyperphosphaturia (HP:0003109) | 2.92493945 |
| 55 | Slow saccadic eye movements (HP:0000514) | 2.90966787 |
| 56 | Abnormality of nucleobase metabolism (HP:0010932) | 2.90623680 |
| 57 | Carpal bone hypoplasia (HP:0001498) | 2.89419801 |
| 58 | Delayed epiphyseal ossification (HP:0002663) | 2.88410338 |
| 59 | Hypokalemia (HP:0002900) | 2.88387349 |
| 60 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.88039832 |
| 61 | Megaloblastic anemia (HP:0001889) | 2.86449707 |
| 62 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.85646435 |
| 63 | Genetic anticipation (HP:0003743) | 2.85387075 |
| 64 | Hypochromic anemia (HP:0001931) | 2.85193985 |
| 65 | Hyperammonemia (HP:0001987) | 2.83634281 |
| 66 | Stomatitis (HP:0010280) | 2.83602616 |
| 67 | Poikilocytosis (HP:0004447) | 2.79945956 |
| 68 | Nausea (HP:0002018) | 2.78018716 |
| 69 | Lethargy (HP:0001254) | 2.76319128 |
| 70 | Renal tubular acidosis (HP:0001947) | 2.75150774 |
| 71 | Obstructive lung disease (HP:0006536) | 2.70887328 |
| 72 | Chronic obstructive pulmonary disease (HP:0006510) | 2.70887328 |
| 73 | Abnormality of serum amino acid levels (HP:0003112) | 2.67616950 |
| 74 | Prolonged bleeding time (HP:0003010) | 2.66549303 |
| 75 | Prolonged neonatal jaundice (HP:0006579) | 2.65098452 |
| 76 | Gastrointestinal infarctions (HP:0005244) | 2.62004738 |
| 77 | Gingivitis (HP:0000230) | 2.57741098 |
| 78 | Abnormality of homocysteine metabolism (HP:0010919) | 2.55029955 |
| 79 | Homocystinuria (HP:0002156) | 2.55029955 |
| 80 | Nephrocalcinosis (HP:0000121) | 2.54088954 |
| 81 | Recurrent cutaneous fungal infections (HP:0011370) | 2.53936916 |
| 82 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.53936916 |
| 83 | Meningitis (HP:0001287) | 2.53639739 |
| 84 | Recurrent skin infections (HP:0001581) | 2.52977907 |
| 85 | Vertebral arch anomaly (HP:0008438) | 2.52836953 |
| 86 | Methylmalonic aciduria (HP:0012120) | 2.52399547 |
| 87 | Pustule (HP:0200039) | 2.52235737 |
| 88 | Leukocytosis (HP:0001974) | 2.52168363 |
| 89 | Abnormal urine phosphate concentration (HP:0012599) | 2.51760519 |
| 90 | Granulocytopenia (HP:0001913) | 2.49672014 |
| 91 | Mediastinal lymphadenopathy (HP:0100721) | 2.48192657 |
| 92 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.47808703 |
| 93 | Papilledema (HP:0001085) | 2.47098637 |
| 94 | Chest pain (HP:0100749) | 2.43576583 |
| 95 | Vacuolated lymphocytes (HP:0001922) | 2.40876739 |
| 96 | Postural instability (HP:0002172) | 2.40701795 |
| 97 | Ketoacidosis (HP:0001993) | 2.36890118 |
| 98 | Diplopia (HP:0000651) | 2.36541409 |
| 99 | Abnormality of binocular vision (HP:0011514) | 2.36541409 |
| 100 | Vomiting (HP:0002013) | 2.34864034 |
| 101 | Confusion (HP:0001289) | 2.34505231 |
| 102 | Autoimmune thrombocytopenia (HP:0001973) | 2.32230687 |
| 103 | Nephrolithiasis (HP:0000787) | 2.31705981 |
| 104 | Metaphyseal cupping (HP:0003021) | 2.30941535 |
| 105 | Thickened calvaria (HP:0002684) | 2.29979592 |
| 106 | Disinhibition (HP:0000734) | 2.27675147 |
| 107 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.26453739 |
| 108 | Abnormality of the fingertips (HP:0001211) | 2.26122123 |
| 109 | Abnormality of potassium homeostasis (HP:0011042) | 2.25560699 |
| 110 | Delayed CNS myelination (HP:0002188) | 2.24831563 |
| 111 | Epistaxis (HP:0000421) | 2.23640601 |
| 112 | Vasculitis (HP:0002633) | 2.22885028 |
| 113 | Hyponatremia (HP:0002902) | 2.21227246 |
| 114 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.20098738 |
| 115 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.19951568 |
| 116 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.19917642 |
| 117 | Nonprogressive disorder (HP:0003680) | 2.18663275 |
| 118 | Pulmonary embolism (HP:0002204) | 2.17628256 |
| 119 | Arterial thrombosis (HP:0004420) | 2.17524804 |
| 120 | Gingival bleeding (HP:0000225) | 2.17028122 |
| 121 | Ketosis (HP:0001946) | 2.16729337 |
| 122 | Ileus (HP:0002595) | 2.16080830 |
| 123 | Rough bone trabeculation (HP:0100670) | 2.14484674 |
| 124 | Recurrent bronchitis (HP:0002837) | 2.12541284 |
| 125 | Papillary thyroid carcinoma (HP:0002895) | 2.12539366 |
| 126 | Panhypogammaglobulinemia (HP:0003139) | 2.12478259 |
| 127 | Urticaria (HP:0001025) | 2.12405399 |
| 128 | Vascular calcification (HP:0004934) | 2.11304965 |
| 129 | Acne (HP:0001061) | 2.11233334 |
| 130 | Abnormality of renal resorption (HP:0011038) | 2.11092696 |
| 131 | Attenuation of retinal blood vessels (HP:0007843) | 2.10225834 |
| 132 | T lymphocytopenia (HP:0005403) | 2.09866443 |
| 133 | Increased IgE level (HP:0003212) | 2.09147142 |
| 134 | Chondrocalcinosis (HP:0000934) | 2.08507442 |
| 135 | Vertigo (HP:0002321) | 2.08419953 |
| 136 | Abnormality of the lumbar spine (HP:0100712) | 2.07984881 |
| 137 | Irritability (HP:0000737) | 2.07772198 |
| 138 | Rickets (HP:0002748) | 2.07625789 |
| 139 | Abnormal trabecular bone morphology (HP:0100671) | 2.06385999 |
| 140 | Facial diplegia (HP:0001349) | 2.05960187 |
| 141 | Abnormality of sodium homeostasis (HP:0010931) | 2.05407636 |
| 142 | Hemoptysis (HP:0002105) | 2.04870827 |
| 143 | Pulmonary infiltrates (HP:0002113) | 2.03379607 |
| 144 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.03115228 |
| 145 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.03115228 |
| 146 | Abnormality of glycolipid metabolism (HP:0010969) | 2.03115228 |
| 147 | Visual hallucinations (HP:0002367) | 2.02477803 |
| 148 | Abnormality of saccadic eye movements (HP:0000570) | 2.02078844 |
| 149 | Abnormality of T cell number (HP:0011839) | 2.02054704 |
| 150 | Bicornuate uterus (HP:0000813) | 2.01587238 |
| 151 | Dehydration (HP:0001944) | 2.01553848 |
| 152 | Hemiplegia (HP:0002301) | 2.00417294 |
| 153 | Widely patent fontanelles and sutures (HP:0004492) | 2.00063391 |
| 154 | Breast hypoplasia (HP:0003187) | 2.00038607 |
| 155 | Xanthomatosis (HP:0000991) | 1.99569015 |
| 156 | Eosinophilia (HP:0001880) | 1.99251373 |
| 157 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.96262108 |
| 158 | 11 pairs of ribs (HP:0000878) | 1.95250864 |
| 159 | Dysostosis multiplex (HP:0000943) | 1.93972459 |
| 160 | Abnormality of the columella (HP:0009929) | 1.93143648 |
| 161 | J-shaped sella turcica (HP:0002680) | 1.92980548 |
| 162 | Abnormality of alanine metabolism (HP:0010916) | 1.92725576 |
| 163 | Hyperalaninemia (HP:0003348) | 1.92725576 |
| 164 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.92725576 |
| 165 | Inflammation of the large intestine (HP:0002037) | 1.92126460 |
| 166 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.91489503 |
| 167 | Abolished electroretinogram (ERG) (HP:0000550) | 1.91202934 |
| 168 | Abnormality of Sharpey fibers (HP:0100685) | 1.90971045 |
| 169 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.90865801 |
| 170 | Athetosis (HP:0002305) | 1.90553888 |
| 171 | Hypoglycemic coma (HP:0001325) | 1.89890750 |
| 172 | Metabolic acidosis (HP:0001942) | 1.89789138 |
| 173 | Abnormal pancreas size (HP:0012094) | 1.89253015 |
| 174 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.89198086 |
| 175 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.88475316 |
| 176 | Renal tubular dysfunction (HP:0000124) | 1.84418819 |
| 177 | Multiple enchondromatosis (HP:0005701) | 1.84347922 |
| 178 | Deformed sella turcica (HP:0002681) | 1.84035922 |
| 179 | Macrocytic anemia (HP:0001972) | 1.83611012 |
| 180 | Flared iliac wings (HP:0002869) | 1.83447048 |
| 181 | Hydroxyprolinuria (HP:0003080) | 1.83174211 |
| 182 | Abnormality of proline metabolism (HP:0010907) | 1.83174211 |
| 183 | Osteomyelitis (HP:0002754) | 1.82612652 |
| 184 | Keratitis (HP:0000491) | 1.82427386 |
| 185 | Cardiovascular calcification (HP:0011915) | 1.81848141 |
| 186 | Thoracic kyphosis (HP:0002942) | 1.80867037 |
| 187 | Abnormality of T cells (HP:0002843) | 1.80865030 |
| 188 | Malnutrition (HP:0004395) | 1.80680278 |
| 189 | Hepatic necrosis (HP:0002605) | 1.80396930 |
| 190 | Petechiae (HP:0000967) | 1.79217636 |
| 191 | Gastrointestinal inflammation (HP:0004386) | 1.78476775 |
| 192 | Thoracolumbar scoliosis (HP:0002944) | 1.77976666 |
| 193 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.77696513 |
| 194 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.77552986 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.69060963 |
| 2 | WNK4 | 5.51342920 |
| 3 | EPHA2 | 5.50043481 |
| 4 | RIPK4 | 4.88796289 |
| 5 | BUB1 | 4.67859627 |
| 6 | OXSR1 | 4.33825390 |
| 7 | WNK3 | 4.02851336 |
| 8 | WEE1 | 3.55678107 |
| 9 | NEK1 | 3.13859006 |
| 10 | STK39 | 2.79361877 |
| 11 | BLK | 2.62182600 |
| 12 | PNCK | 2.47390857 |
| 13 | EIF2AK1 | 2.33501556 |
| 14 | MAP2K3 | 2.31439223 |
| 15 | PRPF4B | 2.29057456 |
| 16 | IRAK4 | 2.26353681 |
| 17 | TTK | 2.21209648 |
| 18 | PDK4 | 2.21207927 |
| 19 | PDK3 | 2.21207927 |
| 20 | ZAK | 2.09234440 |
| 21 | STK16 | 2.04928475 |
| 22 | STK38L | 2.03579896 |
| 23 | TNK2 | 1.95550538 |
| 24 | AKT3 | 1.85577682 |
| 25 | BCKDK | 1.84439735 |
| 26 | PLK4 | 1.74942134 |
| 27 | NME1 | 1.70323413 |
| 28 | YES1 | 1.68308576 |
| 29 | PDK2 | 1.67580220 |
| 30 | CAMK4 | 1.67186596 |
| 31 | MAP3K2 | 1.62113709 |
| 32 | TSSK6 | 1.58125456 |
| 33 | NEK2 | 1.50376389 |
| 34 | NEK6 | 1.49053604 |
| 35 | NME2 | 1.48304810 |
| 36 | FES | 1.44033625 |
| 37 | JAK2 | 1.43241935 |
| 38 | IRAK3 | 1.40320503 |
| 39 | CSK | 1.38630169 |
| 40 | INSRR | 1.38318343 |
| 41 | TYK2 | 1.33297894 |
| 42 | MAPK12 | 1.30699219 |
| 43 | SYK | 1.29305604 |
| 44 | MAPK7 | 1.28091124 |
| 45 | MAP3K3 | 1.26700406 |
| 46 | MAP4K1 | 1.25479262 |
| 47 | FGR | 1.25370270 |
| 48 | BRSK2 | 1.17620503 |
| 49 | PTK2B | 1.15460871 |
| 50 | TXK | 1.13546703 |
| 51 | RPS6KA6 | 1.13523408 |
| 52 | MAP2K6 | 1.13393728 |
| 53 | MST4 | 1.13080270 |
| 54 | IRAK1 | 1.12996851 |
| 55 | HCK | 1.12792933 |
| 56 | NLK | 1.11703616 |
| 57 | PRKCI | 1.08995902 |
| 58 | UHMK1 | 1.08891440 |
| 59 | EIF2AK3 | 1.07997323 |
| 60 | MAP3K7 | 1.07855185 |
| 61 | LYN | 1.06954847 |
| 62 | CAMK1 | 1.03805412 |
| 63 | BTK | 1.03574702 |
| 64 | PINK1 | 1.02890154 |
| 65 | CAMKK1 | 1.02859915 |
| 66 | AURKA | 1.02193857 |
| 67 | RPS6KC1 | 1.01235999 |
| 68 | RPS6KL1 | 1.01235999 |
| 69 | TESK2 | 0.94892954 |
| 70 | STK38 | 0.94393063 |
| 71 | DYRK3 | 0.93071845 |
| 72 | SGK223 | 0.93035789 |
| 73 | SGK494 | 0.93035789 |
| 74 | RPS6KB2 | 0.92866779 |
| 75 | SRPK1 | 0.92619263 |
| 76 | ARAF | 0.88262580 |
| 77 | PLK1 | 0.87522739 |
| 78 | MARK2 | 0.86107701 |
| 79 | IKBKE | 0.85180183 |
| 80 | ABL2 | 0.84007105 |
| 81 | PIK3CG | 0.82724397 |
| 82 | PDK1 | 0.82024062 |
| 83 | MARK1 | 0.82019455 |
| 84 | PAK4 | 0.81732862 |
| 85 | PLK3 | 0.81306083 |
| 86 | RPS6KA5 | 0.79540202 |
| 87 | HIPK2 | 0.78674942 |
| 88 | IKBKB | 0.78322924 |
| 89 | MST1R | 0.78238058 |
| 90 | MAPK13 | 0.77916674 |
| 91 | LCK | 0.77539886 |
| 92 | NTRK3 | 0.75234354 |
| 93 | MAP3K8 | 0.74310635 |
| 94 | CHEK2 | 0.74091083 |
| 95 | STK11 | 0.72771451 |
| 96 | JAK1 | 0.72764411 |
| 97 | MAP2K2 | 0.69615187 |
| 98 | MARK3 | 0.69219526 |
| 99 | SGK1 | 0.68955550 |
| 100 | BRAF | 0.68669825 |
| 101 | BMPR2 | 0.68357322 |
| 102 | SCYL2 | 0.67817351 |
| 103 | DYRK1B | 0.67740916 |
| 104 | CDK12 | 0.65302497 |
| 105 | PAK1 | 0.64150100 |
| 106 | FGFR4 | 0.63898472 |
| 107 | AURKB | 0.63503361 |
| 108 | BRD4 | 0.62010396 |
| 109 | MAP3K1 | 0.60258121 |
| 110 | MAP3K11 | 0.59600088 |
| 111 | SIK2 | 0.58739272 |
| 112 | SGK3 | 0.57803003 |
| 113 | LRRK2 | 0.57435274 |
| 114 | DAPK2 | 0.57405665 |
| 115 | STK10 | 0.56993002 |
| 116 | BRSK1 | 0.53883504 |
| 117 | GRK6 | 0.51028245 |
| 118 | MAP2K4 | 0.50542514 |
| 119 | CAMK1D | 0.50222916 |
| 120 | KSR2 | 0.47175300 |
| 121 | RPS6KA1 | 0.47166115 |
| 122 | ERBB2 | 0.46054094 |
| 123 | CDK4 | 0.43921387 |
| 124 | MAPK4 | 0.43846072 |
| 125 | RET | 0.43000719 |
| 126 | ERN1 | 0.42007011 |
| 127 | PTK2 | 0.41958381 |
| 128 | NTRK2 | 0.41891205 |
| 129 | KDR | 0.41880621 |
| 130 | FYN | 0.41721162 |
| 131 | TEC | 0.41636325 |
| 132 | FGFR3 | 0.39832653 |
| 133 | TAOK1 | 0.39796399 |
| 134 | ITK | 0.39006261 |
| 135 | EPHA4 | 0.38782227 |
| 136 | NEK9 | 0.38393908 |
| 137 | JAK3 | 0.38110219 |
| 138 | TLK1 | 0.37754712 |
| 139 | MAP3K14 | 0.37455778 |
| 140 | SGK2 | 0.34234843 |
| 141 | CSNK1E | 0.33251034 |
| 142 | STK3 | 0.33129644 |
| 143 | LATS2 | 0.32600706 |
| 144 | MET | 0.31680986 |
| 145 | WNK1 | 0.30696735 |
| 146 | GSK3A | 0.29342811 |
| 147 | ACVR1B | 0.28662750 |
| 148 | FER | 0.25909239 |
| 149 | ZAP70 | 0.24986414 |
| 150 | PRKAA1 | 0.24536331 |
| 151 | TAOK2 | 0.24386573 |
| 152 | CAMKK2 | 0.24364421 |
| 153 | PRKCG | 0.21531205 |
| 154 | CAMK2G | 0.21452332 |
| 155 | PRKCD | 0.21412775 |
| 156 | CAMK2B | 0.20856523 |
| 157 | STK4 | 0.20808503 |
| 158 | CSNK1G1 | 0.20257318 |
| 159 | CHEK1 | 0.19698867 |
| 160 | PIM1 | 0.19674778 |
| 161 | PDPK1 | 0.18975564 |
| 162 | PAK3 | 0.18147448 |
| 163 | CCNB1 | 0.18004440 |
| 164 | MELK | 0.16937873 |
| 165 | MAP2K1 | 0.16797100 |
| 166 | CSNK2A1 | 0.16758262 |
| 167 | EPHB1 | 0.16460908 |
| 168 | PIM2 | 0.16042896 |
| 169 | AKT2 | 0.15953260 |
| 170 | CDK2 | 0.15348469 |
| 171 | PRKCZ | 0.15168575 |
| 172 | CSNK2A2 | 0.14872757 |
| 173 | IRAK2 | 0.13702495 |
| 174 | CDK7 | 0.13078105 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.23085262 |
| 2 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.09839713 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.87066496 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.83680363 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.77149123 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.62737612 |
| 7 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.56382920 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.50390956 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.49880479 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.44496931 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.42062316 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.34052088 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.32093377 |
| 14 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.30301262 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 2.15006016 |
| 16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.12513049 |
| 17 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.12270300 |
| 18 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.04208906 |
| 19 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.00811922 |
| 20 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.99936765 |
| 21 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.99917640 |
| 22 | Carbon metabolism_Homo sapiens_hsa01200 | 1.98765333 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.98572660 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.95714215 |
| 25 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.95623874 |
| 26 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.92829573 |
| 27 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.89532862 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.86163887 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.85491379 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.74128421 |
| 31 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.73338880 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.71065520 |
| 33 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.70878567 |
| 34 | Peroxisome_Homo sapiens_hsa04146 | 1.65170916 |
| 35 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.60024792 |
| 36 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.59877511 |
| 37 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.59459033 |
| 38 | Long-term potentiation_Homo sapiens_hsa04720 | 1.55998924 |
| 39 | RNA polymerase_Homo sapiens_hsa03020 | 1.51550090 |
| 40 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.46042980 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.45203485 |
| 42 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.45133693 |
| 43 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.43480348 |
| 44 | Malaria_Homo sapiens_hsa05144 | 1.43449837 |
| 45 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.41932275 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.40791380 |
| 47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.39805981 |
| 48 | Mineral absorption_Homo sapiens_hsa04978 | 1.38445792 |
| 49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.36208020 |
| 50 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.31865726 |
| 51 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.31331569 |
| 52 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.29703728 |
| 53 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.28488976 |
| 54 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.27442282 |
| 55 | Alcoholism_Homo sapiens_hsa05034 | 1.27067389 |
| 56 | Olfactory transduction_Homo sapiens_hsa04740 | 1.25084268 |
| 57 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.24355587 |
| 58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.23864786 |
| 59 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.22967924 |
| 60 | Phagosome_Homo sapiens_hsa04145 | 1.22951625 |
| 61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.22062906 |
| 62 | Ribosome_Homo sapiens_hsa03010 | 1.20019136 |
| 63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19451388 |
| 64 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.18714010 |
| 65 | Renin secretion_Homo sapiens_hsa04924 | 1.18152056 |
| 66 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.17928250 |
| 67 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.17054948 |
| 68 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.16250723 |
| 69 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.15113420 |
| 70 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.14998145 |
| 71 | RNA transport_Homo sapiens_hsa03013 | 1.13692137 |
| 72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.13590490 |
| 73 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.12633275 |
| 74 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.11990614 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.10531522 |
| 76 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.09026311 |
| 77 | Taste transduction_Homo sapiens_hsa04742 | 1.09024825 |
| 78 | Other glycan degradation_Homo sapiens_hsa00511 | 1.06122167 |
| 79 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.01870368 |
| 80 | Measles_Homo sapiens_hsa05162 | 1.00856156 |
| 81 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.00567977 |
| 82 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.99540733 |
| 83 | * Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.98471296 |
| 84 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.96443299 |
| 85 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.95871630 |
| 86 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.95493458 |
| 87 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.95229252 |
| 88 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.94245551 |
| 89 | Lysosome_Homo sapiens_hsa04142 | 0.93648216 |
| 90 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.93424002 |
| 91 | Parkinsons disease_Homo sapiens_hsa05012 | 0.92282373 |
| 92 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.92098738 |
| 93 | DNA replication_Homo sapiens_hsa03030 | 0.90949357 |
| 94 | Platelet activation_Homo sapiens_hsa04611 | 0.90459320 |
| 95 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.89212145 |
| 96 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.88783327 |
| 97 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.87483125 |
| 98 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.85915069 |
| 99 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.85741707 |
| 100 | Histidine metabolism_Homo sapiens_hsa00340 | 0.85392192 |
| 101 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85335694 |
| 102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.83776526 |
| 103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.83754949 |
| 104 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.82840386 |
| 105 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.82743054 |
| 106 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.82725403 |
| 107 | Metabolic pathways_Homo sapiens_hsa01100 | 0.82095154 |
| 108 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.81815704 |
| 109 | GABAergic synapse_Homo sapiens_hsa04727 | 0.80293586 |
| 110 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.80183021 |
| 111 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.79228824 |
| 112 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.78683513 |
| 113 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.78308100 |
| 114 | Legionellosis_Homo sapiens_hsa05134 | 0.78112856 |
| 115 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.77541119 |
| 116 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.77210115 |
| 117 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.76842299 |
| 118 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.76779587 |
| 119 | Circadian entrainment_Homo sapiens_hsa04713 | 0.76151506 |
| 120 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.75214608 |
| 121 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.73585842 |
| 122 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.73255627 |
| 123 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.72870516 |
| 124 | Endometrial cancer_Homo sapiens_hsa05213 | 0.72433571 |
| 125 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.72269243 |
| 126 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.71469090 |
| 127 | Hepatitis B_Homo sapiens_hsa05161 | 0.71346691 |
| 128 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.71221073 |
| 129 | Influenza A_Homo sapiens_hsa05164 | 0.70032587 |
| 130 | Huntingtons disease_Homo sapiens_hsa05016 | 0.68650582 |
| 131 | Bile secretion_Homo sapiens_hsa04976 | 0.68391716 |
| 132 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68011827 |
| 133 | Glioma_Homo sapiens_hsa05214 | 0.67881236 |
| 134 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.67303334 |
| 135 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.66588958 |
| 136 | Morphine addiction_Homo sapiens_hsa05032 | 0.65403664 |
| 137 | Mismatch repair_Homo sapiens_hsa03430 | 0.65247505 |
| 138 | Galactose metabolism_Homo sapiens_hsa00052 | 0.64096966 |
| 139 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.64045993 |
| 140 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.63926716 |
| 141 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.63657444 |
| 142 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63589006 |
| 143 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.61725280 |
| 144 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.61651535 |
| 145 | Cell cycle_Homo sapiens_hsa04110 | 0.61239785 |
| 146 | Spliceosome_Homo sapiens_hsa03040 | 0.61166446 |
| 147 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.61034153 |
| 148 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.60589433 |
| 149 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.60216891 |
| 150 | Allograft rejection_Homo sapiens_hsa05330 | 0.59876944 |
| 151 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.59812135 |
| 152 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.59236742 |
| 153 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58564396 |
| 154 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.58295022 |
| 155 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.58133814 |
| 156 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57489970 |
| 157 | Sulfur relay system_Homo sapiens_hsa04122 | 0.56653844 |
| 158 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.54294928 |
| 159 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52891150 |
| 160 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.51594298 |
| 161 | Apoptosis_Homo sapiens_hsa04210 | 0.50262411 |
| 162 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.49511560 |
| 163 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48851478 |
| 164 | Purine metabolism_Homo sapiens_hsa00230 | 0.48412623 |
| 165 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.48122982 |
| 166 | Lysine degradation_Homo sapiens_hsa00310 | 0.47390632 |
| 167 | Tight junction_Homo sapiens_hsa04530 | 0.46381352 |
| 168 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.46325472 |
| 169 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.45616489 |
| 170 | Base excision repair_Homo sapiens_hsa03410 | 0.45446324 |
| 171 | Retinol metabolism_Homo sapiens_hsa00830 | 0.45299559 |
| 172 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.44602841 |
| 173 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.43924061 |
| 174 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.43306201 |
| 175 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.43175135 |
| 176 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.42821545 |
| 177 | Homologous recombination_Homo sapiens_hsa03440 | 0.41490522 |
| 178 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.36651343 |
| 179 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.34344743 |
| 180 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.34198804 |
| 181 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.34150437 |
| 182 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.33880227 |
| 183 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.31148168 |
| 184 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.29041439 |
| 185 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.27516594 |
| 186 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.27190344 |
| 187 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.23354910 |

